volume 11, issue 3, P227 2021
DOI: 10.3390/life11030227
View full text
|
|
Share
Vanessa Sánchez-Martínez, Cristina Buigues, Rut Navarro-Martínez, Laura García-Villodre, Noura Jeghalef, María Serrano-Carrascosa, José Rubio-Briones, Omar Cauli

Abstract: The relationship between cognitive decline and androgen deprivation therapy (ADT) under luteinizing hormone-releasing hormone (LHRH) analogues is unclear, and there is a scarcity of longitudinal studies considering the interaction between cognition, depressive symptoms and sleep quality in men with prostate cancer (PCa) treated with ADT. This study aimed to determine if there were differences in the scores obtained in cognitive assessment, depressive symptoms, and sleep quality after one year of ADT and determ…

expand abstract